Curetis is not your typical biotech start-up. We are rather a newcomer with many years of multi-disciplinary expertise. Over the past years we have created a healthy growth story. We have convinced our customers and partners, with our pioneering spirit, coupled with the simple aspiration „We care for Diagnostics“, our engineering prowess, and molecular biology and microbiological expertise.
We are not a typical R&D driven company. We rather put our focus on commercial product development. We listen carefully and flexibly react to market and customer demands and needs. We strive to address these by way of pragmatic and intelligent solutions such as Unyvero.
Curetis Provides Update on Unyvero LRT FDA 510(k) Submission
Curetis Provides Business and Financial Update for the First Quarter 2017
ATS - American Thoracic Society, Washington D.C., USA - May 19 to 24, 2017
SHEA - The Society for Healthcare Epidemiology of America, St. Louis, MO, USA - May 29 to 30, 2017